Data for Metabolomic and lipidomic profiles in response to exogenous insulin and GLP-1 infusions during prolonged fasting (Study ST000107)

(Analysis AN000178)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15
C16:0 1.4049 1.1032 1.0197 0.7775 0.3092 1.0424 1.1869 1.1120 0.9703 1.1623 0.9697 0.7372 1.0807 0.3895 0.9162
C16:1n7 1.4236 0.8372 1.2095 0.5213 0.1772 1.2365 1.0551 1.4156 0.9655 1.3004 0.6776 0.5800 0.9411 0.2201 0.8902
C17:0 1.2626 1.0548 1.1128 1.0542 0.3256 1.0822 1.1460 0.9918 1.0458 1.0573 0.9593 0.8684 0.9279 0.4497 0.9556
C18:0 1.1620 1.1990 1.0665 1.3017 0.5305 0.9800 1.0867 0.9167 1.0446 0.9438 1.0165 0.7823 1.0643 0.8364 1.0181
C18:1n7 1.5120 1.1506 1.1191 0.7083 0.1654 1.1641 1.2240 1.0943 1.0169 1.1750 0.7475 0.6140 0.9205 0.2196 0.8769
C18:1n9 1.4459 1.1452 1.0860 0.7645 0.1296 1.2098 1.2887 1.1399 1.0937 1.1604 0.7099 0.5028 0.8351 0.1910 0.8424
C18:2n6 1.4428 1.1948 1.1971 0.7769 0.2228 1.1106 1.1925 1.1107 1.0625 1.1094 0.7532 0.5613 0.8975 0.3143 0.9259
C18:3n3 1.3157 0.8219 1.3425 0.4944 0.2435 1.2252 1.0848 1.2388 0.9917 1.2278 0.6208 0.5560 0.9532 0.1920 0.7853
C20:1n9 1.5160 1.4179 1.2841 0.9109 0.1592 1.2195 1.1755 0.8719 1.1679 0.9546 0.7990 0.6006 0.7335 0.2929 1.0524
C20:3n6 1.5629 1.0541 0.9696 0.9738 0.7921 0.7821 0.8650 0.9843 0.9662 1.2476 1.0993 0.9291 0.9644 0.8862 1.0522
C20:4n6 1.1629 1.2669 1.0955 0.9620 0.6610 0.8796 1.0295 0.9949 1.0029 1.1804 0.8765 0.7936 0.9018 0.8360 1.1673
C20:5n3 1.1787 0.7348 1.0394 0.5025 0.4329 1.2133 1.0172 1.3619 1.0103 1.2121 0.9283 0.7401 1.1342 0.3690 0.6810
C22:5n3 1.2637 1.1003 1.1297 0.6920 0.2739 1.0454 1.1721 1.1763 1.1960 1.2529 0.7442 0.6719 0.6588 0.2968 1.0016
C22:6n3 1.1191 1.0611 1.2615 0.8301 0.6107 1.0118 1.0735 0.9877 1.0322 1.1229 1.0305 0.8146 0.9228 0.6497 1.0933
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Treatment:Early ITT Infusion Study | Timepoint:0 mins
F2Treatment:Early ITT Infusion Study | Timepoint:10 mins
F3Treatment:Early ITT Infusion Study | Timepoint:120 mins
F4Treatment:Early ITT Infusion Study | Timepoint:30 mins
F5Treatment:Early ITT Infusion Study | Timepoint:60 mins
F6Treatment:GLP1/Late GTT | Timepoint:0 mins
F7Treatment:GLP1/Late GTT | Timepoint:10 mins
F8Treatment:GLP1/Late GTT | Timepoint:120 mins
F9Treatment:GLP1/Late GTT | Timepoint:30 mins
F10Treatment:GLP1/Late GTT | Timepoint:60 mins
F11Treatment:Late ITT Infusion Study | Timepoint:0 mins
F12Treatment:Late ITT Infusion Study | Timepoint:10 mins
F13Treatment:Late ITT Infusion Study | Timepoint:120 mins
F14Treatment:Late ITT Infusion Study | Timepoint:30 mins
F15Treatment:Late ITT Infusion Study | Timepoint:60 mins
  logo